341 related articles for article (PubMed ID: 30426802)
1. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
3. The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.
Ständer S; Spellman MC; Kwon P; Yosipovitch G
Expert Opin Investig Drugs; 2019 Aug; 28(8):659-666. PubMed ID: 31272246
[No Abstract] [Full Text] [Related]
4. [Modern systemic therapy for pruritus].
Metz M; Pereira MP
Hautarzt; 2020 Jul; 71(7):518-524. PubMed ID: 32399670
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for the treatment of pruritus.
Ständer S; Weisshaar E; Raap U
Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
[TBL] [Abstract][Full Text] [Related]
6. [Therapy for chronic pruritus-light at the end of a long tunnel?].
Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
[TBL] [Abstract][Full Text] [Related]
7. A New Generation of Treatments for Itch.
Fowler E; Yosipovitch G
Acta Derm Venereol; 2020 Jan; 100(2):adv00027. PubMed ID: 31940047
[TBL] [Abstract][Full Text] [Related]
8. Emerging Therapeutic Options for Chronic Pruritus.
Reszke R; Krajewski P; Szepietowski JC
Am J Clin Dermatol; 2020 Oct; 21(5):601-618. PubMed ID: 32607945
[TBL] [Abstract][Full Text] [Related]
9. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
10. Chronic Pruritus: Current and Emerging Treatment Options.
Pereira MP; Ständer S
Drugs; 2017 Jun; 77(9):999-1007. PubMed ID: 28466423
[TBL] [Abstract][Full Text] [Related]
11. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
12. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
13. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
14. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
15. Advances in therapeutic strategies for the treatment of pruritus.
Stull C; Lavery MJ; Yosipovitch G
Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350
[TBL] [Abstract][Full Text] [Related]
16. Pruritus in connective tissue and other common systemic disease states.
Galatian A; Stearns G; Grau R
Cutis; 2009 Oct; 84(4):207-14. PubMed ID: 19911676
[TBL] [Abstract][Full Text] [Related]
17. Current and emerging systemic treatments targeting the neural system for chronic pruritus.
Golpanian RS; Yosipovitch G
Expert Opin Pharmacother; 2020 Sep; 21(13):1629-1636. PubMed ID: 32515664
[TBL] [Abstract][Full Text] [Related]
18. Investigational drugs for pruritus.
Benecke H; Lotts T; Ständer S
Expert Opin Investig Drugs; 2013 Sep; 22(9):1167-79. PubMed ID: 23815605
[TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for the treatment of chronic pruritic diseases.
Fourzali K; Golpanian RS; Yosipovitch G
Expert Opin Emerg Drugs; 2020 Sep; 25(3):273-284. PubMed ID: 32715798
[TBL] [Abstract][Full Text] [Related]
20. Current treatment strategies in refractory chronic pruritus.
Pereira MP; Mittal A; Ständer S
Curr Opin Pharmacol; 2019 Jun; 46():1-6. PubMed ID: 30530232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]